Literature DB >> 5931270

Primary familial amyloidosis. Ocular manifestations with histopathologic observations.

D Paton, J R Duke.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5931270

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  9 in total

Review 1.  Genetic factors in amyloidosis.

Authors:  P K Thomas
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318

2.  Bilateral amyloidosis of the vitreous body without systemic involvement.

Authors:  T W Lieberman; A P Ferry
Journal:  Trans Am Ophthalmol Soc       Date:  1974

3.  The genetic aspect of the familial amyloidotic polyneuropathy. Portuguese type of paramyloidosis.

Authors:  C Andrade; M Canijo; D Klein; A Kaelin
Journal:  Humangenetik       Date:  1969

4.  Macular lesions secondary to choroidal vascular disorders.

Authors:  S S Hayreh
Journal:  Int Ophthalmol       Date:  1983-02       Impact factor: 2.031

5.  Ocular changes in heredo-oto-ophthalmo-encephalopathy.

Authors:  T Bek
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 6.  Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives.

Authors:  João Heitor Marques; João Coelho; Maria João Menéres; João Melo Beirão
Journal:  Clin Ophthalmol       Date:  2022-07-09

7.  Long-term follow-up of a case of amyloidosis-associated chorioretinopathy.

Authors:  Koichi Nagura; Tatsuya Inoue; Jared Ching; Akinori Sato; Shohei Kitahata; Maiko Maruyama-Inoue; Masaru Takeuchi; Kazuaki Kadonosono
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-02

8.  Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type.

Authors:  A C Silva-Araújo; M A Tavares; J S Cotta; J F Castro-Correia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

9.  Pars plana vitrectomy in a case of amyloidosis of the vitreous.

Authors:  G H van Rens; H F Doubois; J E Winkelman
Journal:  Doc Ophthalmol       Date:  1985-01-31       Impact factor: 2.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.